Clinical Trials Arena on MSN

AbbVie’s Elahere succeeds in Phase II platinum-sensitive ovarian cancer trial

The data from AbbVie’s PICCOLO trial were presented at the SGO meeting 2026.

Percheron raises $2.2 million to back phase II push for HMBD-002

Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured $2.2 million through a fully subscribed entitlement offer, ...
ascopubs.org

A phase II randomized study of neoadjuvant pembrolizumab (P) alone or in combination with vidutolimod (V) in high-risk resectable melanoma: ECOG-ACRIN EA6194.

Randomized phase II study of neoadjuvant (neoadj) anti-PD-1 dostarlimab (D) vs. D + anti-TIM-3 cobolimab (C) in high-risk resectable melanoma (mel) (NEO-MEL-T): Primary analysis. A randomized phase 2 ...
Hosted on MSN

Corvus plans Phase II trial for soquelitinib in atopic dermatitis, targeting 200 patients with 12-week treatment window

CEO Richard A. Miller stated the company's main focus remains the development of soquelitinib for atopic dermatitis, highlighting "an oral medication featuring a novel mechanism of action that so far ...
ascopubs.org

Final results of a phase II study of fruquintinib plus sintilimab as a second-line therapy for advanced gastric and gastroesophageal junction adenocarcinoma (GC/GEJC).

AMIGO: A phase 2 trial of amivantamab in EGFR or MET-amplified gastroesophageal adenocarcinoma (GEA). This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...